Taken together, these results suggest that overexpression of ORMDL3 in obese mice bestows sexual dimorphism of hepatic steatosis, hypercholesterolemia, and exacerbated fibrosis, leading to the early development of NASH characteristics. Here, ORMDL3 is linked to Hepatic steatosis.